Breaking News on Contract Research, Manufacturing & Clinical Trials

CDMO Paragon Bioservices raises $13m in financing

30-Oct-2014 - Contract research and manufacturing organization Paragon Bioservices has raised $13m in a Series A Preferred Stock financing, led by NewSpring Capital and Camden Partners, to continue to grow the company....

News in brief

DPT adds new filling line at San Antonio site in response to customer demand

29-Oct-2014 - DPT has expanded bottle filling capacity with a new line at its manufacturing liquid and semi-solid drugs facility in San Antonio, Texas.

Pharma Action crude heparin plant due to open next week

28-Oct-2014 - A plant being set up by Pharma Action and meat supplier Toennies will produce 15 tonnes of 100% traceable crude heparin a year.

Fujifilm to buy BARDA contractor Kalon Therapeutics

28-Oct-2014 - Texas, US-based GSK influenza vaccine partner Kalon Therapeutics has agreed to a takeover by Japanese conglomerate Fujifilm.

dispatches from bioprocess international

Pall, Thermo Scientific, Fujifilm, Merck Millipore unveil new upstream, downstream offerings

24-Oct-2014 - The products, unveiled at BioProcess International in Boston this week, will help industry with their upstream and downstream processing and include an anti-CHO host cell protein detection kit, the first...

Dispatches from BioProcess International

Shift to single-use means end users ceding more control to suppliers, experts say

22-Oct-2014 - As single-use technology replaces traditional stainless steel technology in biomanufacturing, suppliers will own a larger portion of the supply chain, which is creating anxiety for end users such as Pfizer...

News from CPHI Paris

Doctors ask for quick-dissolve meds to stop in-patient cheating

21-Oct-2014 - Patients receiving court-ordered treatment can be stopped from secretly spitting out their medicines by formulations which dissolve quickly in the mouth.


Polymers make you go faster, greener, say BASF and Colorcon

20-Oct-2014 - BASF, one of the world’s largest chemical companies, has chosen Colorcon to distribute its Kollicoat Immediate Release (IR) tablet coatings.


A bitter pill to swallow: young people dislike tablets more than old

20-Oct-2014 - Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Quality probs and rising wages will see new API hubs replace China and India says analyst

20-Oct-2014 - Analysts predicting a second wave of global API hubs say it will be hard for manufacturers in Latin America, Ukraine and Taiwan to avoid the pitfalls that stymied former high...

news from cphi

CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ

16-Oct-2014 - Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.

News from cphi

Big Pharmas and API suppliers eyeing Brazilian Government deals says EMS

16-Oct-2014 - Government contracts guaranteeing market share in Brazil are starting to attract innovators like Roche, Novartis and Sanofi and may see API suppliers get long-term work according to a spokesman for...

news from the edqm 50th anniversary conference

Food supplements are Europe's real counterfeit drug problem says AIFA expert

15-Oct-2014 - Drug active ingredients in food supplements are Europe’s real falsified medicines problem according to the head of AIFA’s counterfeit prevention team.

News from CPhI

DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIs

14-Oct-2014 - Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers.

Exclusive interview

CDMOs: Leave aseptic manufacturing to the Vetters of this world, says Aesica

14-Oct-2014 - Aesica has turned its back on sterile injectables manufacturing and, in an exclusive interview, told there is now limited steriles capability in the UK following the exit of other...

Capsugel’s French and Belgian Sites Receive EXCiPACT Certification

13-Oct-2014 - The auditing company, SGS, recently certified that Capsugel’s manufacturing sites in Colmar, France and Bornem, Belgium meet Good Manufacturing Practice (GMP) standards set by EXCiPACT for pharmaceutical excipients manufacturing.

Texas A&M licenses Xoma mobile clean room tech citing cost savings and flexibility

10-Oct-2014 - US academics have licensed a mobile clean room design from Xoma for a vaccine and medical countermeasure plant being built in Texas as part of an HHS-funded project.

Share API audits or see quality slump, says Hovione

08-Oct-2014 - The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert the global decline in quality, according to Hovione’s CEO.

Lonza goes with the Flow Chemistry with latest API platform

07-Oct-2014 - Lonza has launched an API-making platform that uses chemical microreaction technology for continuous processing.

Baxter Transitions Biopharma R&D to a New Hub in Cambridge

07-Oct-2014 - Baxter International plans to set up a new global R&D center in Cambridge, Mass, for Baxalta, its biopharmaceuticals spinoff, which is expected be formally incorporated next year and headquartered in...

West outlines plans for Ireland insulin injector plant and future expanisons

06-Oct-2014 - West Pharmaceutical Services plans to expand its global manufacturing operations with a new site in Waterford, Ireland.

Catalent calls for greater academic and industry collaboration on delivery tech

02-Oct-2014 - Catalent has urged industry and academia to share knowledge about delivery technologies to help improve drug efficacy as it signs a deal to develop ADHD treatments for Cingulate.

WuXi expands testing division in US with acquisition of CRO XenoBiotic Laboratories

02-Oct-2014 - China-based WuXi PharmaTech has acquired CRO XenoBiotic Laboratories (XBL) to bolster its bioanalytical and DMPK (Drug Metabolism and Pharmacokinetics)/ADME (absorption, distribution, metabolism, and excretion) services. Financial terms were not disclosed....


Consort Medical cites growing Bespak as driver for £230m Aesica acquisition

30-Sep-2014 - Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Mega deals like Merck-Sigma cut biopharma bargaining power says leading CMO

24-Sep-2014 - Life science sector consolidation is a concern for some biomanufacturers, who say mega mergers like Merck KGaA’s $17bn acquisition of Sigma-Aldrich will limit their ability to negotiate on prices.